Sight Sciences, Inc. financial data

Symbol
SGHT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4040 Campbell Ave,, Suite 100, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.18K % -4.72%
Quick Ratio 54.1 % +9.1%
Debt-to-equity 44.5 % +25.4%
Return On Equity -47.3 % -9.02%
Return On Assets -32.7 % -2.22%
Operating Margin -62.5 % +18.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.8M shares +4.11%
Common Stock, Shares, Outstanding 50.4M shares +4.35%
Entity Public Float 302M USD +4.07%
Common Stock, Value, Issued 50K USD +2.04%
Weighted Average Number of Shares Outstanding, Basic 50.3M shares +3.43%
Weighted Average Number of Shares Outstanding, Diluted 50.3M shares +3.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 79.5M USD -3.99%
Research and Development Expense 17.1M USD -11.6%
Operating Income (Loss) -49.7M USD +21.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -50.1M USD +18.7%
Income Tax Expense (Benefit) 208K USD +89.1%
Net Income (Loss) Attributable to Parent -50.4M USD +18.5%
Earnings Per Share, Basic -1.02 USD/shares +19.7%
Earnings Per Share, Diluted -1.02 USD/shares +19.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 119M USD -17.9%
Accounts Receivable, after Allowance for Credit Loss, Current 12.9M USD -23.6%
Inventory, Net 6.09M USD -34.1%
Assets, Current 140M USD -19.1%
Property, Plant and Equipment, Net 1.45M USD -6.94%
Operating Lease, Right-of-Use Asset 1.1M USD +26.3%
Other Assets, Noncurrent 580K USD -11.5%
Assets 144M USD -18.7%
Accounts Payable, Current 1.3M USD -63.3%
Employee-related Liabilities, Current 7.89M USD +43.4%
Accrued Liabilities, Current 2.45M USD -4.04%
Liabilities, Current 13.8M USD -3.71%
Operating Lease, Liability, Noncurrent 614K USD
Other Liabilities, Noncurrent 689K USD -53.3%
Liabilities 48.6M USD -1.88%
Retained Earnings (Accumulated Deficit) -334M USD -17.7%
Stockholders' Equity Attributable to Parent 95M USD -25.3%
Liabilities and Equity 144M USD -18.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.79M USD +43.7%
Net Cash Provided by (Used in) Financing Activities -942K USD -504%
Net Cash Provided by (Used in) Investing Activities -117K USD +7.14%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 50.4M shares +3.44%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.8M USD +38.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 119M USD -17.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.05M USD +5.19%
Deferred Tax Assets, Valuation Allowance 74.7M USD +21.9%
Deferred Tax Assets, Gross 75M USD +21.7%
Operating Lease, Liability 1.13M USD +24.5%
Depreciation 514K USD -3.2%
Payments to Acquire Property, Plant, and Equipment 117K USD -7.14%
Lessee, Operating Lease, Liability, to be Paid 1.27M USD +32.5%
Property, Plant and Equipment, Gross 3.42M USD +13.2%
Operating Lease, Liability, Current 519K USD -43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 618K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 158K USD -76.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 140K USD +175%
Lessee, Operating Lease, Liability, to be Paid, Year Three 497K USD
Deferred Tax Assets, Operating Loss Carryforwards 60.8M USD +15.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 903K USD +21.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 855K USD -22.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 192K USD +31.5%
Deferred Tax Assets, Net of Valuation Allowance 381K USD -9.72%
Share-based Payment Arrangement, Expense 16.6M USD +15.6%
Interest Expense 4.85M USD -8.14%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%